Oxford University and pharma giant AstraZeneca announced to much fanfare this week that clinical trials were up to 90% effective.
However the group of trial participants who achieved this success rate had actually been given an initial half dose.
The half-dose was given to some people because of an error in the quantity of vaccine put into some vials.
..........It has now emerged the smaller group of less than 3,000 out of 24,000 trial participants on the half-dose-full-dose regime were all under 55.
Doubts grew after none of those details were disclosed in Astra or Oxford’s original statements on Monday.
More at https://tinyurI.com/y4746bhn
However the group of trial participants who achieved this success rate had actually been given an initial half dose.
The half-dose was given to some people because of an error in the quantity of vaccine put into some vials.
..........It has now emerged the smaller group of less than 3,000 out of 24,000 trial participants on the half-dose-full-dose regime were all under 55.
Doubts grew after none of those details were disclosed in Astra or Oxford’s original statements on Monday.
More at https://tinyurI.com/y4746bhn
